VKTX Stock Analysis Today
Updated Nov 7, 2026 · trends, key levels, insider activity and news
Is VKTX bullish or bearish today?
Daily trend: Uptrend (starting) — turns down below $22.96
SEPT signal: Accumulation · Strong Bullish
Research grade: B · fair value $52.05 (+258.7%)
VKTX trend by timeframe
| Daily | Uptrend (starting) |
|---|---|
| 4 hour | Strong Bullish |
| 1 hour | Strong Bullish |
| 15 min | Strong Bullish |
| 5 min | Strong Bullish |
Trends are calculated from price structure and update during market hours.
VKTX support and resistance levels
Resistance (above)
$27.9017 touches
$29.882 touches
$31.7024 touches
Support (below)
$25.775 touches
$23.8210 touches
$21.231 touches
Upside zones: $29.21 / $29.57 / $29.93
See all levels on the live chart →Insider and institutional activity
Insiders
Neutral30-day buys / sells
0 / 030-day net
—Hedge fund holders
365Latest VKTX news and filings
- AnalystBenzinga
Canaccord Genuity keeps Buy rating on Viking Therapeutics, lifts target to $118
Canaccord Genuity reiterated its Buy rating on Viking Therapeutics and raised its price target to $118. The change reflects the analyst's updated view on the stock.
- EarningsFiscal.ai
Viking Therapeutics posts Q3 2026 results and trial updates
Viking Therapeutics released its third quarter 2026 financial results along with an update on its clinical trial progress. The report covers the company's latest financial position and the status of its ongoing studies.
- AnalystGoldman Sachs
Goldman Sachs kept its Neutral rating on Viking Therapeutics (VKTX) and lowered its price target to $34 from $38.
- EarningsFiscal.ai
Viking Therapeutics Posts Q3 2026 Financials
The biotech company released its quarterly financial figures for the period ending in 2026. The filing covers its latest earnings performance.
- EarningsBenzinga
Viking Therapeutics posts quarterly loss of $1.55 per share
The drug developer's third-quarter loss came in at $1.55 per share, wider than the $1.07 loss analysts had projected. The result fell short of consensus expectations.
Live VKTX chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is VKTX bullish or bearish today?
VKTX daily trend: Uptrend (starting) — turns down below $22.959. SEPT signal: Accumulation (Strong Bullish). Updated Nov 7, 2026.
What is VKTX's trend on each timeframe?
Daily: Uptrend (starting); 4 hour: Strong Bullish; 1 hour: Strong Bullish; 15 min: Strong Bullish; 5 min: Strong Bullish.
What are VKTX support and resistance levels?
Support: $25.77, $23.82, $21.23. Resistance: $27.90, $29.88, $31.70. Last price $26.84.
Are insiders buying or selling VKTX?
Insider signal: Neutral. Last 30 days: 0 buys, 0 sells. 365 hedge funds hold VKTX.
What is the latest news on VKTX?
Oct 30, 2026: Canaccord Genuity keeps Buy rating on Viking Therapeutics, lifts target to $118 · Oct 30, 2026: Viking Therapeutics posts Q3 2026 results and trial updates · Oct 29, 2026: Goldman Sachs kept its Neutral rating on Viking Therapeutics (VKTX) and lowered its price target to $34 from $38.